摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,6-bis(4'-hydroxy-3',5'-dimethoxyphenyl)-3,7-dioxabicyclo[3.3.0]octane-4,8-dione | 41514-36-7

中文名称
——
中文别名
——
英文名称
2,6-bis(4'-hydroxy-3',5'-dimethoxyphenyl)-3,7-dioxabicyclo[3.3.0]octane-4,8-dione
英文别名
dehydrosinapinic acid dilactone;sinapic acid dimer;(1S,3aS,4S,6aS)-1,4-bis(4-hydroxy-3,5-dimethoxyphenyl)-1,3a,4,6a-tetrahydrofuro[3,4-c]furan-3,6-dione
2,6-bis(4'-hydroxy-3',5'-dimethoxyphenyl)-3,7-dioxabicyclo[3.3.0]octane-4,8-dione化学式
CAS
41514-36-7;63324-54-9;63427-87-2;65167-29-5
化学式
C22H22O10
mdl
——
分子量
446.411
InChiKey
SOYZXRMXOYGADU-XAMWDVODSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    726.7±60.0 °C(Predicted)
  • 密度:
    1.398±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    32
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    130
  • 氢给体数:
    2
  • 氢受体数:
    10

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    胸苷酸的合成
    摘要:
    通过将芥子酸(6)氧化苯酚偶联至双内酯(7),然后进行酸催化的重排,通过两个步骤合成了托马斯二酸(2)。脱苄基化和碱水解后,通过苄基化然后通过LAH还原从硫代二酸二甲酯(9)衍生而来的二醇二苄基醚(15)被选择性氧化,生成胸苷酸(1)。
    DOI:
    10.1016/0040-4020(73)80192-9
  • 作为产物:
    描述:
    3,5-二甲氧基-4-羟基肉桂酸三氯化铁 作用下, 以 乙醇 为溶剂, 反应 1.0h, 以75%的产率得到2,6-bis(4'-hydroxy-3',5'-dimethoxyphenyl)-3,7-dioxabicyclo[3.3.0]octane-4,8-dione
    参考文献:
    名称:
    Phellinsin A 的立体化学:α-亚芳基-γ-内酯的简明合成
    摘要:
    摘要 以简洁的方式制备了Phellinsin A (1a),从而阐明了1a 中芳基和羧酸基团的相对立体化学。该合成采用了源自肉桂酸衍生物氧化二聚化的双内酯的选择性单水解。该方法为α-亚芳基-γ-内酯的合成提供了一条实用的途径。
    DOI:
    10.1081/scc-200054845
点击查看最新优质反应信息

文献信息

  • Synthesis of thomasic acid
    作者:R. Ahmed、M. Lehrer、R. Stevenson
    DOI:10.1016/0040-4020(73)80192-9
    日期:1973.1
    Thomasidioic acid (2) has been synthesized in two steps by oxidative phenol coupling of sinapic acid (6) to the dilactone (7) followed by acid-catalyzed rearrangement. The diol dibenzyl ether (15), derived from thomasidioic acid dimethyl ester (9) by benzylation followed by LAH reduction, was selectively oxidized to yield thomasic acid (1) after debenzylation and base hydrolysis.
    通过将芥子酸(6)氧化苯酚偶联至双内酯(7),然后进行酸催化的重排,通过两个步骤合成了托马斯二酸(2)。脱苄基化和碱水解后,通过苄基化然后通过LAH还原从硫代二酸二甲酯(9)衍生而来的二醇二苄基醚(15)被选择性氧化,生成胸苷酸(1)。
  • Hydroxycinnamic Acids as DNA-Cleaving Agents in the Presence of Cu<sup>II</sup>Ions: Mechanism, Structure–Activity Relationship, and Biological Implications
    作者:Gui-Juan Fan、Xiao-Ling Jin、Yi-Ping Qian、Qi Wang、Ru-Ting Yang、Fang Dai、Jiang-Jiang Tang、Ya-Jing Shang、Li-Xia Cheng、Jie Yang、Bo Zhou
    DOI:10.1002/chem.200901627
    日期:2009.11.23
    The effectiveness of hydroxycinnamic acids (HCAs), that is, caffeic acid (CaA), chlorogenic acid (ChA), sinapic acid (SA), ferulic acid (FA), 3‐hydroxycinnamic acid (3‐HCA), and 4‐hydroxycinnamic acid (4‐HCA), as pBR322 plasmid DNA‐cleaving agents in the presence of CuII ions was investigated. Compounds bearing o‐hydroxy or 3,5‐dimethoxy groups on phenolic rings (CaA, SA, and ChA) were remarkably more
    羟基肉桂酸(HCA)的有效性,即咖啡酸(CaA),绿原酸(ChA),芥子酸(SA),阿魏酸(FA),3-羟基肉桂酸(3-HCA)和4-羟基肉桂酸酸(4-HCA),作为在Cu II离子存在下的pBR322质粒DNA裂解剂进行了研究。酚环上带有邻羟基或3,5-二甲氧基的化合物(CaA,SA和ChA)比不带有此类基团的化合物更有效地引起DNA损伤。此外,在所检查的HCA中,CaA是最活跃的。通过使用特定的清除剂ROS和Cu I抑制DNA断裂,证实了活性氧(ROS)和Cu I离子参与了DNA损伤。螯合剂。还研究了CaA和Cu II离子之间的相互作用以及乙二胺四乙酸(EDTA),溶剂和pH值对相互作用的影响,以帮助通过UV / Vis光谱分析阐明详细的前氧化机理。根据这些观察结果,建议是由CaA酚酸根阴离子而不是母体分子与Cu II离子作为双齿配体螯合,从而促进分子内电子转移形成相应的CaA半醌自由
  • Nishiyama, Atsuko; Eto, Hideo; Terada, Yukimasa, Chemical and pharmaceutical bulletin, 1983, vol. 31, # 8, p. 2845 - 2852
    作者:Nishiyama, Atsuko、Eto, Hideo、Terada, Yukimasa、Iguchi, Masanobu、Yamamura, Shosuke
    DOI:——
    日期:——
  • Formation of thomasidioic acid from dehydrosinapinic acid dilactone under neutral conditions, and a remaining inhibitory activity against peroxynitrite-mediated protein nitration
    作者:Toshio Niwa、Umeyuki Doi、Toshihiko Osawa
    DOI:10.1016/s0960-894x(02)00059-8
    日期:2002.3
    Dehydrosinapinic acid dilactone (1) was converted to thomasidioic acid (3) and (E,E)-2,3-bis(3,5-dimethoxy-4-hydroxybenzylidene)succinic acid (4) via an a,p-unsaturated gamma-lactone type dimer (2) in phosphate buffer (pH 7.4). A study of the reaction mechanism was accomplished by observing the reaction of methyl ester of 2. The lignans (3, 4) were also prevented the peroxynitrite-mediated protein nitration. (C) 2002 Elsevier Science Ltd. All rights reserved.
  • Biotransformation of Sinapic Acid Catalyzed by <i>Momordica charantia</i> Peroxidase
    作者:Hai-Li Liu、Xiang Wan、Xue-Feng Huang、Ling-Yi Kong
    DOI:10.1021/jf0628072
    日期:2007.2.1
    Biotransformation of sinapic acid (1) with H2O2/Momordica charantia peroxidase, which exists in the widely used food M. charantia, at pH 5.0, 43 degrees C, in the presence of acetone resulted in six compounds, including four new compounds. Compound 2 was the first isolation of a new unique sinapic acid tetrameric derivate, which is formed by peroxidase catalysis in vitro. Besides 2, three other new sinapic acid dimers, 3-5 have also been isolated. Their structures were established on the basis of spectroscopic data. Compound 5 showed a stronger antioxidative activity than the parent sinapic acid (1). Compounds 4 and 5 significantly inhibited the growth of HL-60 cell at the concentration of 10(-5) mol/L.
查看更多

同类化合物

鬼臼脂毒酮 鬼臼毒素-4-O-葡萄糖苷 鬼臼毒素 鬼臼毒素 苦鬼臼毒素 脱氧鬼臼毒素 磷酸依托泊甙 盾叶鬼臼素 澳白木脂素2 澳白木脂素1 替尼泊苷 托尼依托泊苷 去氧鬼臼毒素 克立米星C 他氟泊苷 丙氨酸,N-(羧基甲基)-(9CI) alpha-盾叶鬼臼素 alpha-依托泊苷 [(5R,5aR,8aR,9R)-9-(4-羟基-3,5-二甲氧基-苯基)-8-氧代-5a,6,8a,9-四氢-5H-异苯并呋喃并[5,6-f][1,3]苯并二氧戊环-5-基]丁酸酯 TOP-53二盐酸盐 NK-611盐酸盐 5,8,8a,9-四氢-9-羟基-5-(3,4,5-三甲氧基苯基)-(5R,5aR,8aR,9S)-呋喃并[3',4':6,7]萘并[2,3-d]-1,3-二氧杂环戊烯-6(5aH)-酮 4’-去甲鬼臼毒素 4’-去甲基表鬼臼毒素-Β-D-葡萄糖甙 4-{[(5S,5aS,8aR,9R)-9-(4-羟基-3,5-二甲氧苯基)-8-羰基-5,5a,6,8,8a,9-六氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-5-基]氨基甲酰}苯基乙酸酯 4,6-O-苄叉-Β-D-葡萄糖甙鬼臼毒素 4'-去甲基表鬼臼毒素 4'-O-脱甲基-4-((4'-(1'-苯甲基哌啶基))氨基)-4-脱氧鬼臼毒 4 ’-去甲去氧鬼臼毒素 3-羟基-4H-吡喃-4-酮 3-氨基-N-[(5S,5aS,8aR,9R)-9-(4-羟基-3,5-二甲氧苯基)-8-羰基-5,5a,6,8,8a,9-六氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-5-基]苯酰胺 2’-O-没食子酰基金丝桃甙 2(3H)-硫代酰苯,3-乙基二氢-3-(1-甲基乙基)-(9CI) 2'-氯依托泊苷 1-羟基-17-氧杂五环[6.6.5.0~2,7~.0~9,14~.0~15,19~]十九碳-2,4,6,9,11,13-六烯-16,18-二酮(non-preferredname) (8aR,9S)-9-[[(2R)-7,8-二羟基-2-(2-噻吩基)-4,4a,6,7,8,8a-六氢吡喃并[5,6-d][1,3]二恶英-6-基]氧基]-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5S,5aS,8aR,9R)-5-[(4-氟苯基)氨基]-9-(4-羟基-3,5-二甲氧基-苯基)-5a,6,8a,9-四氢-5H-异苯并呋喃并[5,6-f][1,3]苯并二氧戊环-8-酮 (5S,5aR,8aR,9R)-9-(4-羟基-3,5-二甲氧基-苯基)-5-(4-羟基苯基)硫烷基-5a,6,8a,9-四氢-5H-异苯并呋喃并[5,6-f][1,3]苯并二噁唑-8-酮 (5R,5aR,8aS,9S)-9-[(4-氨基苯基)氨基]-5-(4-羟基-3,5-二甲氧苯基)-5,8,8a,9-四氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-6(5aH)-酮盐酸(1:1) (5R,5aR,8aR,9R)-9-羟基-10-甲氧基-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-9-[[(6R,7R,8R)-7,8-二羟基-2-(4-甲氧基苯基)-4,4a,6,7,8,8a-六氢吡喃并[5,6-d][1,3]二恶英-6-基]氧基]-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-F][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-9-[[(6R,7R,8R)-7,8-二羟基-2-(2-羟基苯基)-4,4a,6,7,8,8a-六氢吡喃并[5,6-d][1,3]二恶英-6-基]氧基]-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-F][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-8-羰基-9-(3,4,5-三甲氧苯基)-5,5a,6,8,8a,9-六氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-5-基乙酸酯 (5R,5aR,8aR,9R)-5-(4-乙氧基-3,5-二甲氧基-苯基)-9-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-5-(3,5-二甲氧基-4-丙氧基-苯基)-9-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5R)-5,8,8ab,9-四氢-5b-(3,4,5-三甲氧基苯基)呋喃并[3',4':6,7]萘并[2,3-d]-1,3-二氧杂环戊烯-6(5abH),9-二酮 (5-氯吡啶-3-基)丙酸甲酯 (3aS,4S,9R,9aR)-4-[(4-氟苯基)氨基]-9-(4-羟基-3,5-二甲氧基苯基)-6,7-二甲氧基-3a,4,9,9a-四氢-3H-萘并[3,2-c]呋喃-1-酮 (3aR,4S,9R,9aR)-4,6,7-三羟基-9-(4-羟基-3,5-二甲氧苯基)-3a,4,9,9a-四氢萘并[2,3-c]呋喃-1(3H)-酮 (1R,3aS,4R,6aR)-4-(1,3-苯并二氧戊环-4-基)-1-(1,3-苯并二氧戊环-5-基)-3,3a,4,6a-四氢-1H-呋喃并[3,4-c]呋喃-6-酮